Diclofenac sodium releasing pH-sensitive monolithic devices


Basan H., Gumusderelioglu M., Orbey T.

INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol.245, no.1-2, pp.191-198, 2002 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 245 Issue: 1-2
  • Publication Date: 2002
  • Doi Number: 10.1016/s0378-5173(02)00350-2
  • Journal Name: INTERNATIONAL JOURNAL OF PHARMACEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.191-198
  • Keywords: diclofenac sodium, hydrogel, drug release, pH-sensitive polymers, MATRIX TABLETS, DRUG-DELIVERY, IN-VITRO, HYDROGELS, FORMULATION, IMPLANTS, PHEMA, VIVO
  • Gazi University Affiliated: Yes

Abstract

A non-steroidal anti-inflammatory agent, diclofenac sodium (DFNa), was incorporated into the pH-sensitive monolithic systems prepared by crosslinking/copolymerization of 2-hydroxyethyl methacrylate (HEMA) with acrylate-based acidic and basic comonomers, i.e. acrylic acid (AA) and dimethylaminoethyl methacrylate (DMAEMA). Drug loading was done before polymerization and crosslinking. Hence, DFNa-containing polymeric discs approximately 10 mm in diameter and 3.0 mm in thickness were obtained. In vitro release studies were carried out in simulated gastric fluid for 3 h followed by simulated intestinal fluid at 37 degreesC. The release rate of DFNa was controlled by changing the composition of polymeric matrix, disc thickness and the drug loading between 5 and 33 mg/disc. Results indicate that in the low pH of the stomach, swelling degree of the AA-containing gels is low and less than 5% of the drug releases during first 3 h. But, in the intestine, the high pH causes the higher swelling degree of the AA-containing discs, allowing all the drug ( similar to 97.5%) is released. In the presence of DMAEMA in polymeric structure, opposite behavior was observed. (C) 2002 Published by Elsevier Science B.V.